New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
|Articles|October 19, 2016
CDC Updates HPV Vaccine Recommendations for Younger Adolescents
Author(s)Contagion Editorial Staff
The new Centers for Disease Control and Prevention (CDC) recommendations call for a revised dosing schedule.
Advertisement
According to a recent press release, the Centers for Disease Control and Prevention (CDC) has updated their guidelines on human papillomavirus (HPV) vaccination, recommending that, “11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses.”
Tom Frieden, MD, MPH, Director of the CDC is quoted in the release as saying, “Safe, effective, and long-lasting protection against HPV cancers with two visits instead of three means more Americans will be protected from cancer. This recommendation will make it simpler for parents to get their children protected in time.”
This decision comes after Dr. Frieden approved the Advisory Committee on Immunization Practices (ACIP) vote to recommend the 2-dose vaccine schedule. The CDC and ACIP recommendations come after the institutions “reviewed data from clinical trials showing two doses of HPV vaccine in younger adolescents (aged 9-14 years) produced an immune response similar or higher than the response in young adults (aged 16-26 years) who received three doses.”
Younger adolescents are scheduled to receive the HPV vaccine along with the whooping cough and meningitis vaccines. According to the press release, this new 2-dose regimen for adolescents ages 11 and 12 years, “will provide safe, effective, and long-lasting protection against HPV cancers.” Adolescents who are ages 13 and 14 will also be able to receive the new 2-dose schedule of the vaccine.
Earlier this month, the US Food and Drug Administration
Advertisement
Related to this article
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Advertisement
Advertisement